Clinical Trials Logo
  1. Home
  2. Hypersomnia
  3. NCT03198156

Transcranial Direct Current Stimulation Therapy for Central Hypersomnia Without Cataplexy — tDCS  

Hypersomnia Clinical Trial

Official title:
Transcranial Direct Current Stimulation Therapy for Central Hypersomnia Without Cataplexy

Clinical Trial Summary

1. To determine the effects of transcranial direct current stimulation (tDCS) on vigilance in subjects with central hypersomnia without cataplexy. 2. To determine the effects of tDCS on subjective measures of sleepiness and alertness in subjects with central hypersomnia without cataplexy.

Clinical Trial Description

This is a randomized, sham-controlled, parallel group study. The study will last up to 5 weeks. After informed consent, subjects with idiopathic hypersomnia with an MSLT mean sleep latency of >8 minutes will undergo actigraphy and those with an average sleep time of >10 hours per day will continue with the study while those with <10 hours sleep time will be excluded. In addition, OSA subjects with complaints of hypersomnia with an ESS score <10 will also be excluded. Female subjects of child bearing age and not menopausal will have a pregnancy test performed as pregnancy is an exclusionary criteria. Subjects will be randomized to receive either active tDCS or sham stimulation for 30 minutes daily for 4 sessions. The randomization will be generated by means of a computer-generated random-number table. An unrestricted randomization scheme will be followed. Subjects will be blinded as to whether they are receiving sham or active tDCS treatments. The investigator who will conduct the analysis of all outcomes will be blinded as to subject treatment assignment. All stimulation visits will be completed within a five-consecutive day period; that is one stimulation visit may be missed provided a total of four stimulation visits are completed within a five-day period. Outcome measures will include: psychomotor vigilance test (PVT), subjective measures of sleepiness, and the Center for Epidemiologic Studies Depression (CES-D) scale. PVT will be performed pre- and post- stimulation during the first and last stimulation sessions. Subjective measures of sleepiness include the following: Epworth Sleepiness Scale (ESS), Stanford Sleepiness Scale (SSS), Functional Outcomes of Sleep Questionnaire-10 (FOSQ-10), and Visual Analogue Scale (VAS). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03198156
Study type Interventional
Source Ohio State University
Contact
Status Terminated
Phase N/A
Start date September 1, 2017
Completion date June 20, 2020
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05983731 - A Pilot Observational Study to Assess the Ability of Continuous 'Home' EEG to Accurately Diagnose Narcolepsy and Demonstrate Response to Treatment
Withdrawn NCT03626727 - Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia Early Phase 1
Completed NCT01183312 - Flumazenil for the Treatment of Primary Hypersomnia Phase 1/Phase 2
Completed NCT03682185 - The Healthy Patterns Sleep Study Phase 3
Completed NCT00916253 - Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies N/A
Completed NCT04157244 - The Music, Sleep and Dementia Study N/A
Recruiting NCT05443373 - A Multi-Signal Based Monitoring System for CNS Hypersomnias
Completed NCT01877616 - Sleep Disorders and Their Cardiovascular Correlates in Atahualpa. N/A
Suspended NCT00427323 - Light Exposure to Treat Sleep Disruption in Older People N/A
Not yet recruiting NCT04300166 - Telemedicine and Humidification for Cpap IN Osas Key Treatment (THINK Study) N/A
Not yet recruiting NCT06404086 - RECOVER-SLEEP: Platform Protocol Phase 2
Not yet recruiting NCT06404099 - RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia) Phase 2
Completed NCT01146600 - Clarithromycin for the Treatment of Hypersomnia Phase 2
Withdrawn NCT05627388 - Feasibility Study of At-Home EEG Monitoring for Hypersomnia N/A
Completed NCT01764035 - Mindfulness Therapy on Disrupted Sleep in Bipolar Disorder N/A
Completed NCT03459300 - Importance of Sleep Deprivation in Differential Diagnosis of Primary Hypersomnia (Actisom dépistage)
Completed NCT00001664 - Sleep Disorders of Patients With Diseases of the Nervous System N/A
Recruiting NCT04201392 - Sleep in Psychiatric Inpatients
Suspended NCT05230394 - Patient Outcomes in Unattended and In- Lab Polysomnography N/A
Terminated NCT01544465 - Structured Physical Activity for Sleep Quality and Daytime Sleepiness in Patients With Parkinson's Disease N/A